Drug Profile
SCH 497079
Alternative Names: SCH-497079Latest Information Update: 27 May 2010
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Obesity therapies
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity